Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any brachydactyly type E in which the cause of the disease is a mutation in the PTHLH gene.
Features include sometimes findings: Delayed eruption of teeth and Oligodontia. 6 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Growth and development | 1 | Short stature |
PTHLH function has not been fully characterized.
Brachydactyly type E2 is associated with mutations in the PTHLH gene on chromosome 12.
Genetic testing for PTHLH is available. Testing is considered confirmatory for diagnosis.
No clinical trials have been registered for brachydactyly type E2.
3 publications have been identified in PubMed for brachydactyly type E2. Research spans Basic Science / Preclinical (67%) and Review / Meta-Analysis (33%).
Wang X (2025). [PMID: 40589517](https://pubmed.ncbi.nlm.nih.gov/40589517/). *Front Endocrinol (Lausanne)*. [Basic Science / Preclinical]
Zhu S (2024). [PMID: 38956429](https://pubmed.ncbi.nlm.nih.gov/38956429/). *Cell Discov*. [Review / Meta-Analysis]
Andersen RE (2024). [PMID: 38946951](https://pubmed.ncbi.nlm.nih.gov/38946951/). *medRxiv*. [Basic Science / Preclinical]
Data assembled from 5 of 12 sources · Last updated Sep 17, 2026, 7:49 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center